Tarmim Ava

Tarmim Ava is dedicated to advancing technical expertise and indigenous knowledge within the regenerative medicine sector. Established in February 2020, Tarmim Ava focuses on tissue engineering, striving to commercialize innovative dermal substitutes, biopatches, nanobiopatches, and advanced dressings for wound and burn care.

In addition to their work in tissue engineering, Tarmim Ava is developing solutions for infertility treatment and PRP kits, with plans to introduce these products to the market soon. Demonstrating agility and commitment to public health, Tarmim Ava has also prioritized the production of a mesenchymal stem cell-derived drug under the brand name Mezexo in response to the global COVID-19 pandemic.

Tarmim Ava is also deeply involved in pioneering paracrine therapy using stem cells, conducting clinical trials in dermatology, hair restoration, ophthalmology, and orthopedics. We invite the manager of Tarmim Ava to create a customized and exclusive company showcase and product listing on our platform, highlighting your contributions to regenerative medicine.